The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
May 14th 2024
The artificial intelligence (AI)-powered module provides a prostate segmentation tool for MRI-guided transurethral ultrasound ablation (TULSA) procedures in patients with prostate cancer.
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
May 21, 2024
Register Now!
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
23rd Annual International Congress on the Future of Breast Cancer® West
July 12-13, 2024
Register Now!
25th Annual International Lung Cancer Congress®
July 25-27, 2024
Register Now!
2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Is that your nose growing, doctor?
July 1st 2007How much would you pay to avoid spending the rest of your life in prison: $2 million? How about 30 years in prison: $1 million? Even if we lowball it and say a radiologist makes about $250,000 a year, 30 years of your life would be worth more like $7.5 million. What if I told you it would cost you only $10,000. A steal, right?
Sonography reveals causes of acute or chronic groin pain
July 1st 2007Groin pain, whether acute or chronic, is a common clinical presentation that can be caused by a diverse array of disorders involving different anatomic structures. This makes definitive diagnosis difficult for even the most experienced clinician. Imaging can be invaluable in both localizing and characterizing otherwise uncertain groin pathology.
Early results from Alzheimer’s neuroimaging studies could speed research
June 19th 2007Alzheimer’s disease researchers may be able to reduce the time and expense associated with clinical trials, according to early results from the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a public-private research partnership organized by the National Institutes of Health.
Ultrasound proves equal to MRI for assessing heart valve in cardiomyopathy
June 18th 2007Real-time 3D echocardiography can measure mitral annular size and function as accurately as MRI, according to Egyptian researchers. They studied patients with both hypertrophic cardiomyopathy and dilated cardiomyopathy.
Report from SNM: Hybrid PET/MR imaging of brain debuts at annual meeting
June 5th 2007Researchers from Germany and the U.S. released findings from the first study showing images of the human brain acquired simultaneously by the two modalities of a hybrid PET/MR scanner. They released the data at the 2007 Society of Nuclear Medicine meeting being held in Washington, DC.
Initial research challenges contrast reaction dogma
June 1st 2007Contrary to conventional wisdom, patients with life-threatening adverse reactions to contrast media may be truly allergic to certain agents, the same way people are allergic to dust or pollen. The evidence so far is preliminary, but if it is borne out by further research, the finding would have significant implications for the administration of contrast agents.
Baby-boomers can expect better imaging of age-related changes
June 1st 2007If ever a generation has been obsessed with aging, it's the baby-boom generation. Thirty years' worth of fads in exercise, diets, fashion, and personal grooming have all been directed at slowing the aging process or hiding its effects. Well, boomers can run (or jog, or bike, or yoga), but they won't be able to hide from what radiologists may soon be able to tell about the age of their insides.
Agfa plans ahead for coming demise of best-of-breed IT products
June 1st 2007When the best-of-breed information systems that now facilitate the practice of medicine have outlived their usefulness, Agfa Healthcare will be ready with the next generation of IT, if the president of Agfa Healthcare has his way.
European radiologists bask in glow of MR blood pool images
June 1st 2007Peripheral MR angiography is improved on first-pass imaging due to the high relaxivity of the MR blood pool agent Vasovist. The extended imaging window provided by the agent supports steady-state imaging not possible with other MR contrast media, producing ultrahigh spatial resolution MRA (second pass) demonstrating both arteries and veins in detail.
Diffusion maps of bone mets indicate therapy response
June 1st 2007Diffusion-weighted MR of the bone may indicate within days whether and how well patients with metastatic cancer of the bone are responding to treatment. The software to support such conclusions is now being developed for commercial release later this year by Cedara Software.
MRI, CT offer answers to renal mass queries
June 1st 2007The widespread use of cross-sectional imaging techniques means that renal masses are now a common incidental finding. The term renal mass covers a diverse group of pathologic entities, including inflammatory, vascular, and benign tumors and neoplastic lesions.
3T MRI accurately stages rectal cancer, identifies candidates for sphincter-sparing surgery
May 25th 2007Patients examined at the Qilu Hospital of Shandong University in China for rectal cancer benefit from the added diagnostic power of 3T MRI for staging and identifying candidates for sphincter-sparing surgery.
Report from ISMRM: Dutch group gives vote of confidence to 3T MR-guided prostate interventions
May 25th 2007MR-guided biopsies at 3T are showing great promise in prostate cancer because of their speed and high tumor detection rate in patients with rising PSA levels and previous negative biopsies, according to a leading research team from the Netherlands. They also do well in patients who have had previous radiotherapy sessions.
Radiology researchers from Johns Hopkins strike gold in poster hall
May 24th 2007The two most prestigious poster awards were bestowed on research teams from the radiology department of Johns Hopkins University in Baltimore, Maryland, at the ISMRM-ESMRMB congress on Thursday. Another top prize went to a team from Stanford University in California.
Panel recommends caution in administration of contrast in the wake of gadolinium-related NSF cases
May 24th 2007Nephrogenic systemic fibrosis is the train radiologists never saw coming. NSF is a painful, debilitating, possibly fatal skin disorder that has been linked to chelated gadolinium contrast media administered prior to MRI for patients with renal disorder. More than 200 cases have been confirmed worldwide.
Siemens proves feasibility of MR/PET hybrid
May 24th 2007The first brain images produced simultaneously with a prototype MR/PET scanner were shown at the Siemens Medical Solutions booth and in a scientific session in Berlin. The device, currently in development at a Siemens lab, integrates a PET detector into the bore of a 3T scanner.
Report from ISMRM: Research shows how MRI and PET/CT can work together in cancer assessments
May 24th 2007Preliminary studies presented Tuesday at the International Society for Magnetic Resonance in Medicine meeting in Berlin gave radiologists a glimpse of future imaging practices for cancer patients: a molecular nuclear imaging test to assess the extent of hypoxia and functional MRI to monitor the response of head and neck carcinoma to treatment.
Dutch group gives vote of confidence to 3T MR-guided prostate interventions
May 23rd 2007MR-guided biopsies at 3T are showing great promise in prostate cancer because of their speed and high tumor detection rate in patients with rising PSA levels and previous negative biopsies, according to a leading research team from the Netherlands. They also do well in patients who have had previous radiotherapy sessions.
Low-cost MR scanner opens door to wide-scale diabetes, breast imaging
May 23rd 2007A novel low-field electromagnetic MR scanner has the potential to deliver high-quality images, even in the presence of metal implants, and can do so for radically less than the cost of conventional superconducting magnets.
Functional MRI reveals new findings in brains of diabetic patients
May 23rd 2007Researchers in the U.K. have used functional MR imaging to show that patients with diabetic peripheral neuropathy (DPN) respond differently to heat and pain stimulation compared with diabetic patients without peripheral neuropathy.
Danish study finds novel solution to problems in high-field MRI of brain
May 23rd 2007The use of sensitivity encoding and a gradient echo sequence in dynamic susceptibility contrast (DSC) perfusion imaging at 3T leads to fewer artifacts and better diagnostic quality, according to award-winning research from Denmark.